Tagged: VRUS

Gilead Sciences to Acquire Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD), a biopharmaceutical company engaged in the development and commercialization of human therapeutics for life threatening diseases, today entered into a definitive agreement with Pharmasset Inc. (NASDAQ: VRUS) under which...

Stocks Remain in Red in Mid-Day Trading

Stocks have remained in red in mid-day trading. All three major indexes have been pushed lower by some weak euro zone and U.S. economic data. At last check, the Dow Jones was trading 0.72%...